Johnson & Johnson has signaled that it will attempt to disqualify certain plaintiffs' lawyers and use other aggressive ...

Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian cancer.

Toxicity related to the systematic delivery of IL-12, a well-known and widely researched anti-tumor cytokine, has limited its ...

STORY: A U.S. judge has rejected Johnson & Johnson’s $10 billion bid to settle lawsuits claiming its talc products caused ...

University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial ...

ArtemiCafe Coffee shows positive results from a Phase 1 ovarian clinical trial conducted by Markey Cancer Center.

Lopez said J&J's proposed settlement did not have sufficient support from women who alleged J ... alleging that its baby ...

University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial ...

A judge rejected Johnson & Johnson’s proposed $9 billion settlement to end lawsuits claiming its talc-based products caused ovarian cancer.

Lopez said J&J’s proposed settlement did not have sufficient support from women who ... The brand’s baby powder and talc products allegedly cause ovarian cancer. J&J “unnecessarily rushed ...

A U.S. bankruptcy judge has denied Johnson & Johnson's settlement plan relating to its baby powder products containing talc.